ABSTRACT
INTRODUCTION
The availability of complete genome sequences for a wide variety of microbial species has revolutionized microbiology. Although bioinformatics tools permit phylogenetic classification of the majority of the putative gene products into conserved classes (16) , the annotation of function based on sequence alone is still, by its very nature, a hypothesis. Experimentation is required to test and refine these hypotheses. For many of these organisms, however, the genetic toolkit available is limited, at best. One key genetic hurdle slowing progress is the lack of facile tools to generate unmarked mutant strains in a wide variety of organisms. The generation of unmarked mutants allows for multiple genetic manipulations of organisms for which few antibiotic markers exist. In recent years, a growing number of systems for antibiotic marker recycling in non-enteric bacteria have been reported that utilize a variety of site-specific recombination systems and antibiotic markers (5) . These include the utilization of the RP4 multimer resolution system (8) and both the yeast Flp/FRT (7) and P1 phage cre/lox (2) site-specific recombination systems. This paper describes the development of a simple broad-host-range antibiotic marker recycling system based on crelox methodology. Cre recombinase is a site-specific recombinase from the P1 phage that catalyzes in vivo excision of DNA regions flanked by co-directional loxP recognition sites (12) . The system we describe consists of a mobilizable allelic exchange vector with a loxPflanked antibiotic resistance cassette, pCM184 or pCM351, and an IncP plasmid that expresses the Cre recombinase, pCM157 or pCM158. We demonstrate the broad utility of this system by generating unmarked mutant strains of two phylogenetically distinct Gramnegative bacteria, Methylobacterium extorquens AM1 (an α-proteobacterium) and Burkholderia fungorum LB400 (a β-proteobacterium).
MATERIALS AND METHODS

Media and Growth Conditions
M. extorquens AM1 (11) and B. fungorum LB400 (3) strains were grown on a minimal salts medium (1) containing carbon sources at the following levels, 0.2% citrate, 0.5% (v/v) methanol, and 0.4% (w/v) succinate. E. coli strains were grown on LB medium (14) (strains and plasmids are described in Table 1 ). Antibiotics were added at the following final concentrations, unless noted: 50 µg/mL ampicillin, 10 µg/mL chloramphenicol, 50 µg/mL (for E. coli and M. extorquens AM1), or 20 µg/mL (for B. fungorum LB400) kanamycin, 50 µg/ mL rifamycin, 35 µg/mL streptomycin, and 10 µg/mL tetracycline. Chemicals were obtained from Sigma (St. Louis, MO, USA). Nutrient agar and Bactoagar were obtained from Difco (Detroit, MI, USA). Conjugation was performed as described previously (4) . biotic resistance cassettes into a variant of the mobilizable suicide plasmid, pAYC61 (4). The 1.3-kb HincII fragment bearing the kanamycin resistance cassette from pUC4K (17) was inserted into pLox1 (12) , which had been cut with XbaI and blunted, to create pCM161. To introduce convenient multiple cloning sites, the loxP-bounded kanamycin cassette of pCM161 was amplified with following primer pair, CM-ufkMCS, 5′-TGACGTCTAGATC-TGAATTCAGCTGTACAATTGGTA-CCATGGATGCATATGGCGGCCG-CA-3′, and CM-dfkMCS, 5′-GACTA-GTGAGCTCACCGGTTAACACGC-GTACGTAGGGCCCGCGGTATCGA-TAAGCTGGATCC-3′. The resulting 1.4-kb PCR product was purified and cloned into pCR2.1 (Invitrogen, Carlsbad, CA, USA) to create pCM183. To preserve useful cloning sites, pAYC61 was cut with EcoRI and SmaI, blunted using T4 DNA polymerase, and selfligated to produce pCM182. Finally, the 1.4-kb AatII-SpeI fragment from pCM183 containing the loxP-flanked kanamycin cassette was ligated between the AatII and XbaI sites of pCM182 to create pCM184 (Gen- Bank ® accession no. AY093429). A gentamycin-resistance conferring version, pCM351, was also generated. The loxP-flanked gentamycin-resistance cassette (encoded by aaaC1) was amplified from pLoxGen4 (12), using CM-ufkMCS and CM-dfkMCS, and cloned into pCR2.1 (Invitrogen) to produce pCM350. The 1-kb AatII/SacI fragment from pCM350 was cloned between the AatII and SacI sites of pCM184 to generate pCM351 (GenBank accession no. AY093430). Two broad-host-range cre expression vectors, pCM157 and pCM158 ( Figure 2 ), were created based on a pair of small, mobilizable IncP plasmids (10). The 1.1-kb XbaI-EcoRI fragment from pJW168 (19) was cloned between the XbaI and EcoRI sites of pCM62 (10) to generate the tetracycline-resistance conferring cre expression plasmid pCM157. A kanamycin-resistant version, pCM158, was generated by cloning the same XbaI-EcoRI fragment from pJW168 between the XbaI and EcoRI sites of pCM66 (10) . These plasmids contain cre behind the E. coli lac promoter. In M. extorquens AM1, this promoter provides only low constitutive activity (10) . Despite this low expression, the majority of cells obtained from the first passage onto plates lacking kanamycin are already kanamycin sensitive (data not shown).
Generation of a ∆ ∆fae Mutant of M. extorquens AM1
M. extorquens AM1 mutants defective for fae (encodes formaldehyde-activating enzyme) (18) were generated using pCM184 (Figure 2 ). The regions immediately flanking fae were amplified by PCR using the following primer pairs: CM-Dfae1, 5′-CGGGTTTCGT-GACCTGTTC-3′, and CM-Dfae2, 5′-GTTATGCGGCCGCCATCTGCATG-GAAGCCATCCTTGTTTGC-3′; and CM-Dfae3, 5′-GCTTATCGATACCG-TCGACCTCGAGGCAGTCCTGGG-CAGA-3′, and CM-Dfae4, 5′-CGGGC-ATCGAGCGTTTCAC-3′. The purified PCR products for fae-upstream and fae-downstream were cloned into pCR2.1 to produce pCM195 and
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Vol. 33, No. 5 (2002) pCM196, respectively. The 0.6-kb EcoRI-NotI fragment from pCM195 was introduced between the EcoRI and NotI sites of pCM184 to produce pCM197. Subsequently, the 0.6-kb ApaI-SacI fragment from pCM196 was ligated between the ApaI and SacI sites of pCM197 to produce pCM198.
A ∆fae::kan mutant of M. extorquens AM1 was generated by introducing pCM198 by conjugation from E. coli S17-1 (15) . Kanamycin-resistant transconjugants obtained on succinate medium containing rifamycin were screened for tetracycline sensitivity to identify potential null mutants. To date, our laboratory has generated more than 30 different null mutant strains utilizing this system, and the frequency of double-crossover events has varied from 5% to 80% (unpublished data). One such ∆fae::kan mutant, CM198K.1, was chosen for further study. The plasmid pCM157 was introduced by conju- Antibiotic resistances are indicated as follows, Ap (ampicillin), Gm (gentamycin), Kn (kanamycin), Rif (rifamycin), Sm (streptomycin), and Tc (tetracycline).
Table 1. Bacterial Strains and Plasmids Used in This Study
gation into CM198K.1 using the helper plasmid pRK2073 (6) . Tetracycline-resistant strains were streaked for purity until the resulting strain produced only kanamycin-sensitive colonies (generally only two transfers). Subsequently, pCM157 was cured from the strain by two successive transfers on medium lacking tetracycline to produce the ∆fae strain CM198.1. Analytical PCR was performed with wild-type M. extorquens AM1, CM198K.1, and CM198.1 for the confirmation of allelic exchange and the subsequent deletion of the kanamycin cassette (data not shown).
Where examined, the sequence of the analytical PCR product indicated faithful recombination between the loxP sites (data not shown).
Generation of a ∆ ∆flhA Mutant of B. fungorum LB400
B. fungorum LB400 mutants defective for flhA (predicted to encode a NAD-and glutathione-dependent formaldehyde dehydrogenase) (13) were generated using pCM184, as described earlier with M. extorquens AM1. The regions flanking flhA were amplified by PCR using the following primer pairs: CM-BfflhAuf, 5′-GGTGACGG-CATTGAAGCTG-3′, and CM-BfflhAur, 5′-CATGCATCTTTGGTCTTC-ATCGTGAATG-3′; and CM-BfflhAdf, 5′-ACCGCGGTCGTGCTGTACTAAT-CC-3′, and CM-BfflhAur, 5′-AGAGC-TCGATACCGACCGATAGATCTC-3′. The flhA upstream and downstream PCR products were cloned into pCR2.1 (Invitrogen) to produce pCM360 and pCM361, respectively. The 0.6-kb SacII-SacI downstream fragment from pCM361 was introduced between the SacII and SacI sites of pCM184 to produce pCM362. Subsequently, the 0.5-kb EcoRI-NsiI upstream fragment from pCM360 was ligated between the EcoRI and NsiI sites of pCM362 to produce pCM363.
A ∆flhA::kan mutant of B. fungorum LB400 was generated by introducing pCM363 by conjugation. Kanamycinresistant transconjugants were obtained on citrate medium containing chloramphenicol (wild-type B. fungorum LB-400 was found to be naturally resistant below 10-20 µg/mL). One tetracyclinesensitive strain representing a ∆flhA:: kan mutant, CM363K.1, was chosen for further study. The plasmid pCM157 was used as described earlier to produce the ∆flhA strain CM363.1. Analytical PCR was performed with wildtype B. fungorum LB400, CM363K.1, and CM363.1 for confirmation (data not shown).
The minimal inhibitory concentration of formaldehyde was determined by comparing the rate and extent of colony formation of wild-type B. fungorum LB400 to that of the flhA mutants CM363K.1 and CM363.1 on solid medium containing succinate as a growth substrate with various concentrations of formaldehyde. Formaldehyde was added to the plates immediately before the addition of the molten agar. Because an undetermined fraction of the formaldehyde will volatilize, the reported minimal inhibitory concentration of formaldehyde is a maximum value.
RESULTS AND DISCUSSION
To test the broad-host-range cre-lox antibiotic marker recycling system, unmarked mutants were generated in M. extorquens AM1 (an α-proteobacterium) and B. fungorum LB400 (a β-proteobacterium). Analytical PCR confirmed replacement of each deleted gene with kan and the subsequent excision of kan to produce the unmarked deletion (data not shown). The ∆fae mutant of M. extorquens AM1 grew like the wild-type on succinate but failed to grow on methanol or medium containing succinate and methanol. This mutant phenotype is in agreement with previous observations with a fae::kan mutant (18). The CM198.1 ∆fae strain can serve as a convenient host for structure-function studies that require the expression of variant Fae proteins.
As a second demonstration of this broad-host-range antibiotic marker recycling system, a ∆flhA mutant of B. fungorum LB400 was generated. In other bacteria, the flhA gene encodes a glutathione-dependent formaldehyde dehydrogenase (13) . This enzyme is involved in formaldehyde detoxification in E. coli (9) and Paracoccus denitrificans (13) and is required for methylotrophic growth by the latter. The ∆flhA strain CM363.1 was found to be somewhat more sensitive to the presence of formaldehyde during growth on citrate than wild-type B. fungorum LB400, with a minimal inhibitory concentration of 0.1 mM compared to 0.2 mM for the wild-type. This finding demonstrates that the glutathione-dependent pathway is involved in formaldehyde detoxification across multiple branches of the proteobacteria.
In conclusion, this new broad-hostrange cre-lox antibiotic marker recycling system offers the possibility to create unmarked mutants in a wide variety of Gram-negative bacteria. Utilization of allelic exchange with counter-selection against integrants and an inherently unstable minimal IncP Cre expression plasmid obviates the need for successful negative selection in the target organism, a feature of some previously developed marker recycling systems (7) . The use of PCR to generate flanks for gene replacement allows for the facile generation of precise deletion mutants (Figure 3) , as well as truncations through the introduction of start or stop codons in the primers, as needed. Variants of this system can be readily developed to allow the construction of chromosomal transcriptional or translational fusions (T. Strovas, C.J. Marx, and M.E. Lidstrom, unpublished data). Marker recycling systems such as ours described here offer a substantial advantage over standard allelic exchange methods because it can be used iteratively to enable the generation of unmarked strains bearing multiple genetic modifications. Our laboratory has already used this system to generate an M. extorquens AM1 strain bearing four separate mutations (C.J. Marx, L. Chistoserdova, and M.E. Lidstrom, unpublished data). Finally, engineered strains generated with these tools are more acceptable for environmental release, owing to the absence of introduced antibiotic resistance markers.
